These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12113892)
21. Development and validation of a direct, non-destructive quantitative method for medroxyprogesterone acetate in a pharmaceutical suspension using FT-Raman spectroscopy. De Beer TR; Vergote GJ; Baeyens WR; Remon JP; Vervaet C; Verpoort F Eur J Pharm Sci; 2004 Dec; 23(4-5):355-62. PubMed ID: 15567288 [TBL] [Abstract][Full Text] [Related]
22. Screening suspect pharmaceuticals for illicit designer benzodiazepines using raman, SERS, and FT-IR prior to comprehensive analysis using LC-MS. Kimani MM; Smith SW; Lanzarotta A; Brueggemeyer JL; Batson JS Forensic Sci Int; 2022 Sep; 338():111390. PubMed ID: 35870307 [TBL] [Abstract][Full Text] [Related]
23. [Pioglitazone hydrochloride a instrumental analytical perspective by Raman spectroscopy and HPLC]. Vértiz-Beltrán JF; Avila-Rodríguez R; Terrones-Gurrola R; Abelardo Camacho L; Rangel-López A; Campos-Cantón I; Vértiz-Hernández AA Rev Invest Clin; 2014; 66(4):351-8. PubMed ID: 25695301 [TBL] [Abstract][Full Text] [Related]
24. Investigation of the composition of anabolic tablets using near infrared spectroscopy and Raman chemical imaging. Rebiere H; Ghyselinck C; Lempereur L; Brenier C Drug Test Anal; 2016; 8(3-4):370-7. PubMed ID: 26198290 [TBL] [Abstract][Full Text] [Related]
25. Rapid screening of 2-benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART-TD-MS, and FT-IR. Kimani MM; Kern S; Lanzarotta A; Thatcher M; Lorenz LM; Smith SW; Collins M; Howe GW; Wetherby AE Drug Test Anal; 2023 May; 15(5):539-550. PubMed ID: 36648419 [TBL] [Abstract][Full Text] [Related]
26. Composition profiling of seized ecstasy tablets by Raman spectroscopy. Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550 [TBL] [Abstract][Full Text] [Related]
27. Matrix Effects in Quantitative Assessment of Pharmaceutical Tablets Using Transmission Raman and Near-Infrared (NIR) Spectroscopy. Sparén A; Hartman M; Fransson M; Johansson J; Svensson O Appl Spectrosc; 2015 May; 69(5):580-9. PubMed ID: 25811389 [TBL] [Abstract][Full Text] [Related]
28. Application of Deep-Learning Algorithm Driven Intelligent Raman Spectroscopy Methodology to Quality Control in the Manufacturing Process of Guanxinning Tablets. Tao Y; Bao J; Liu Q; Liu L; Zhu J Molecules; 2022 Oct; 27(20):. PubMed ID: 36296563 [TBL] [Abstract][Full Text] [Related]
29. Detecting and identifying the complexation of nimodipine with hydroxypropyl-beta-cyclodextrin present in tablets by Raman spectroscopy. Yang X; Ke W; Zi P; Liu F; Yu L J Pharm Sci; 2008 Jul; 97(7):2702-19. PubMed ID: 17918724 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride. Mandal S; Ray R; Basu SK; Sa B J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689 [TBL] [Abstract][Full Text] [Related]
31. Comparison of the determination of a low-concentration active ingredient in pharmaceutical tablets by backscatter and transmission Raman spectrometry. Townshend N; Nordon A; Littlejohn D; Myrick M; Andrews J; Dallin P Anal Chem; 2012 Jun; 84(11):4671-6. PubMed ID: 22533444 [TBL] [Abstract][Full Text] [Related]
32. Raman spectroscopy as a complementary tool to assess the content uniformity of dosage units in break-scored warfarin tablets. Arruabarrena J; Coello J; Maspoch S Int J Pharm; 2014 Apr; 465(1-2):299-305. PubMed ID: 24508332 [TBL] [Abstract][Full Text] [Related]
33. Quantitative polymorph contaminant analysis in tablets using Raman and near infra-red spectroscopies. Hennigan MC; Ryder AG J Pharm Biomed Anal; 2013 Jan; 72():163-71. PubMed ID: 23146243 [TBL] [Abstract][Full Text] [Related]
34. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride. al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034 [TBL] [Abstract][Full Text] [Related]
35. Vapor Phase Alkyne Coating of Pharmaceutical Excipients: Discrimination Enhancement of Raman Chemical Imaging for Tablets. Yamashita M; Sasaki H; Moriyama K J Pharm Sci; 2015 Dec; 104(12):4093-4098. PubMed ID: 26343262 [TBL] [Abstract][Full Text] [Related]
36. Nondestructive determination of the ambroxol content in tablets by Raman spectroscopy. Hwang MS; Cho S; Chung H; Woo YA J Pharm Biomed Anal; 2005 Jun; 38(2):210-5. PubMed ID: 15925210 [TBL] [Abstract][Full Text] [Related]
37. [Simple method for quantitative determination of active polymorphous and amorphous drugs in drug products by fourier transform-Raman spectroscopy]. Ueno T; Urakami K; Higashi A; Umemoto K; Godo M; Kitamura K Yakugaku Zasshi; 2005 Oct; 125(10):807-14. PubMed ID: 16205038 [TBL] [Abstract][Full Text] [Related]
38. Validation of a direct non-destructive quantitative analysis of amiodarone hydrochloride in Angoron((R)) formulations using FT-Raman spectroscopy. Orkoula MG; Kontoyannis CG; Markopoulou CK; Koundourellis JE Talanta; 2007 Sep; 73(2):258-61. PubMed ID: 19073025 [TBL] [Abstract][Full Text] [Related]
40. A validated method for the analysis of diltiazem in raw materials and pharmaceutical formulations by rp-HPLC. Sultana N; Arayne MS; Shafi N Pak J Pharm Sci; 2007 Oct; 20(4):284-90. PubMed ID: 17604250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]